Respiratory Syncytial Virus clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
The overarching hypothesis of the ARRC trial is that administration of Azithromycin (AZM) during acute, Respiratory Syncytial Virus (RSV)-induced respiratory failure will be beneficial, mediated through the matrix metalloproteinase (MMP)-9 pathway.
San Francisco, California and other locations